| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0896-8411(03)00114-8 |
| P698 | PubMed publication ID | 14599847 |
| P50 | author | Bhagirath Singh | Q57196187 |
| P2093 | author name string | Hui-Yu Qin | |
| Pratibha Chaturvedi | |||
| Rinee Mukherjee | |||
| P2860 | cites work | CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms | Q24673863 |
| Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation | Q24676080 | ||
| A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells | Q24678065 | ||
| Dendritic cells and the control of immunity | Q27860918 | ||
| B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes | Q28143530 | ||
| A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis | Q29619339 | ||
| CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production | Q29619536 | ||
| TGF-beta: the missing link in CD4+CD25+ regulatory T cell-mediated immunosuppression | Q33338215 | ||
| Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23) | Q33592891 | ||
| An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation | Q33876035 | ||
| Regulatory T cells in autoimmmunity*. | Q33904108 | ||
| Regulatory T cells: key controllers of immunologic self-tolerance | Q33941140 | ||
| The role of different subsets of T regulatory cells in controlling autoimmunity | Q34096248 | ||
| Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance | Q34111451 | ||
| CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor | Q34116317 | ||
| IFN-gamma production by antigen-presenting cells: mechanisms emerge. | Q34382913 | ||
| Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance | Q34448410 | ||
| Control of T-cell activation by CD4+ CD25+ suppressor T cells | Q34448423 | ||
| The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. | Q34452348 | ||
| Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta | Q34517421 | ||
| Transforming growth factor-beta in T-cell biology | Q34572232 | ||
| Multiple roles for tumor necrosis factor-alpha and lymphotoxin alpha/beta in immunity and autoimmunity | Q34731168 | ||
| A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin | Q36007054 | ||
| T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice | Q36356330 | ||
| CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells | Q36361889 | ||
| Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice | Q36361909 | ||
| Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation | Q36367099 | ||
| Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells | Q36367622 | ||
| Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation | Q36369726 | ||
| Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures | Q36376739 | ||
| Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients | Q37356987 | ||
| Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. | Q37683001 | ||
| Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. | Q37925551 | ||
| Insulin-dependent diabetes mellitus as a beta-cell targeted disease of immunoregulation | Q40377775 | ||
| Tumour necrosis factor-alpha but not lipopolysaccharide enhances preference of murine dendritic cells for Th2 differentiation | Q40678768 | ||
| Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen | Q40701079 | ||
| T regulatory cells 1 inhibit a Th2-specific response in vivo | Q40846695 | ||
| Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 | ||
| Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific | Q40910998 | ||
| Induction of apoptosis in mature T cells by tumour necrosis factor | Q41293478 | ||
| The role of TNF alpha and related cytokines in the development and function of the autoreactive T-cell repertoire | Q41628498 | ||
| Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state | Q42466421 | ||
| Autoreactive diabetogenic T-cells in NOD mice can efficiently expand from a greatly reduced precursor pool | Q42657755 | ||
| Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice | Q46570289 | ||
| Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency | Q47992795 | ||
| TGF-β1 down-regulates Th2 development and results in decreased IL-4-induced STAT6 activation and GATA-3 expression | Q56987564 | ||
| The transfer of autoimmune diabetes in NOD mice can be inhibited or accelerated by distinct cell populations present in normal splenocytes taken from young males | Q68087911 | ||
| Antigen based therapies to prevent diabetes in NOD mice | Q71557201 | ||
| Prophylactic oral administration of metabolically active insulin entrapped in isobutylcyanoacrylate nanocapsules reduces the incidence of diabetes in nonobese diabetic mice | Q73258353 | ||
| Characterization of peripheral regulatory CD4+ T cells that prevent diabetes onset in nonobese diabetic mice | Q73289663 | ||
| Increased T cell autoreactivity in the absence of CD40-CD40 ligand interactions: a role of CD40 in regulatory T cell development | Q73311881 | ||
| A self MHC class II beta-chain peptide prevents diabetes in nonobese diabetic mice | Q73869271 | ||
| A dual role for TNF-alpha in type 1 diabetes: islet-specific expression abrogates the ongoing autoimmune process when induced late but not early during pathogenesis | Q73966607 | ||
| Naturally anergic and suppressive CD25(+)CD4(+) T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation | Q74080415 | ||
| T cell memory | Q74578125 | ||
| The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7 | Q74650540 | ||
| Protection from insulin dependent diabetes mellitus afforded by insulin antigens in incomplete Freund's adjuvant depends on route of administration | Q74741683 | ||
| Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells | Q77291206 | ||
| Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis | Q78404404 | ||
| P433 | issue | 3 | |
| P921 | main subject | preproinsulin | Q7240673 |
| P304 | page(s) | 221-237 | |
| P577 | publication date | 2003-11-01 | |
| P1433 | published in | Journal of Autoimmunity | Q15716783 |
| P1476 | title | CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells | |
| P478 | volume | 21 |
| Q36339559 | Adoptive transfer of immunomodulatory M2 macrophages prevents type 1 diabetes in NOD mice |
| Q35248766 | Analysis of T cell receptor beta chains that combine with dominant conserved TRAV5D-4*04 anti-insulin B:9-23 alpha chains |
| Q36327362 | Antigen-specific induction of regulatory T cells for type 1 diabetes therapy |
| Q36906673 | Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease |
| Q33750667 | Banting Lecture 2009: An unfinished journey: molecular pathogenesis to prevention of type 1A diabetes |
| Q36766623 | Conserved T cell receptor alpha-chain induces insulin autoantibodies |
| Q38766469 | Cutting Edge: Dual TCRα Expression Poses an Autoimmune Hazard by Limiting Regulatory T Cell Generation |
| Q33932462 | De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25- cells |
| Q33797147 | Differentiated all-trans retinoic acid response of naive CD4+CD25- cells isolated from rats with collagen-induced arthritis and healthy ones under in vitro conditions |
| Q52726744 | Early Growth Response Gene 2-Expressing CD4+LAG3+ Regulatory T Cells: The Therapeutic Potential for Treating Autoimmune Diseases. |
| Q35990538 | Expansion of CD4+CD25+ suppressive regulatory T cells from rhesus macaque peripheral blood by FN18/antihuman CD28-coated Dynal beads |
| Q36249780 | Immune regulatory properties of allogeneic adipose-derived mesenchymal stem cells in the treatment of experimental autoimmune diabetes. |
| Q36449594 | Incomplete depletion and rapid regeneration of Foxp3+ regulatory T cells following anti-CD25 treatment in malaria-infected mice |
| Q48630939 | Modulating the immune system through nanotechnology. |
| Q24604014 | Modulation of autoimmune diseases by interleukin (IL)-17 producing regulatory T helper (Th17) cells |
| Q37737987 | Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease |
| Q34263542 | Perspectives on Regulatory T Cell Therapies |
| Q84582129 | Prevention of type 1 diabetes through infection with an intestinal nematode parasite requires IL-10 in the absence of a Th2-type response |
| Q34345367 | Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice |
| Q83168646 | Pro-apoptotic DNA vaccination ameliorates new onset of autoimmune diabetes in NOD mice and induces foxp3+ regulatory T cells in vitro |
| Q35101668 | Protection against autoimmune diabetes by silkworm-produced GFP-tagged CTB-insulin fusion protein. |
| Q37235106 | Regulation of autoimmune arthritis by self-heat-shock proteins |
| Q41948987 | Regulatory T cells, a potent immunoregulatory target for CAM researchers: modulating tumor immunity, autoimmunity and alloreactive immunity (III). |
| Q36563537 | Regulatory T-cell physiology and application to treat autoimmunity |
| Q35896345 | Regulatory T-cells in type 1 diabetes |
| Q39277444 | Restimulation-induced cell death: new medical and research perspectives. |
| Q39451535 | Role of TGF-β in Self-Peptide Regulation of Autoimmunity |
| Q36076495 | Self heat-shock protein 65-mediated regulation of autoimmune arthritis |
| Q34023585 | Subcutaneous insulin B:9-23/IFA immunisation induces Tregs that control late-stage prediabetes in NOD mice through IL-10 and IFNgamma |
| Q37358159 | TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes |
| Q26822824 | The impact of anti-inflammatory cytokines on the pancreatic β-cell |
| Q36287487 | The murine diabetogenic class II histocompatibility molecule I-Ag7: structural and functional properties and specificity of peptide selection |
| Q36885374 | The vicious cycle of apoptotic beta-cell death in type 1 diabetes |
| Q52674851 | Therapeutic Potential of Gene-Modified Regulatory T Cells: From Bench to Bedside. |
| Q34355286 | Virtual optimization of nasal insulin therapy predicts immunization frequency to be crucial for diabetes protection |
Search more.